Uptake and Survival Outcomes Following Immune Checkpoint Inhibitor Therapy among Trial-Ineligible Patients with Advanced Solid Cancers
JAMA Oncology（2021）
Key words
Intratumor Heterogeneity,Treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined